Megan Garlapow, PhD

All articles by Megan Garlapow, PhD

• Training improved nurses’ skills in managing obstetric emergencies

  A two-day simulation-based course improved nurses’ readiness to treat obstetric crises linked to FNAIT and other complications.

• Study: Transfusions trigger inflammation that may affect FNAIT outcomes

  Platelet unit storage time and mitochondrial DNA levels influenced inflammatory responses that could affect FNAIT complications.

• New findings may ease concerns about rare antibody type in FNAIT

  Researchers found no anti–HPA-1a antibodies that bind only to αvβ3 in maternal blood from patients with FNAIT.

• Training program improved transfusion skills and patient safety

  A six-month transfusion medicine program enhanced the trainees’ clinical skills, helping to prevent complications associated with conditions like FNAIT.

• Review highlights current strategies to prevent infant brain bleeds

  Preventative intravenous immunoglobulin therapy can lower risks in FNAIT, though some experts disagree on when and how to use it.

• Study: Thrombocytopenia predicted severe complications in infants

  Thrombocytopenia, a platelet disorder linked to FNAIT, was a major predictor of serious illness in preterm infants in a recent study.

• Case report shows potential link between FNAIT and preeclampsia

  A case report suggested that in some cases, preeclampsia may not be a separate condition but a consequence of FNAIT.

• Lower platelets may worsen breathing risks in premature infants

  Premature infants with low platelets, often tied to FNAIT, experienced longer hospital stays and more severe breathing problems.

• Early diagnosis and treatment improve survival in FNAIT

  Faster diagnosis and modern treatment strategies now give most babies with FNAIT a much better chance of survival and recovery.

• Clinical trial to test nipocalimab vs IVIG to prevent FNAIT

  A new trial is testing whether nipocalimab can lower the risk of severe bleeding and death in babies at risk of FNAIT.